{"id":"https://openalex.org/W7093123710","doi":null,"title":"P142 | ROMIPLOSTIM AS A TREATMENT FOR CHEMOTHERAPY INDUCED THROMBOCYTOPENIA: THREE CASE REPORTS AND A LITERATURE REVIEW","display_name":"P142 | ROMIPLOSTIM AS A TREATMENT FOR CHEMOTHERAPY INDUCED THROMBOCYTOPENIA: THREE CASE REPORTS AND A LITERATURE REVIEW","publication_year":2025,"publication_date":"2025-09-01","ids":{"openalex":"https://openalex.org/W7093123710"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:eec1995cebd24287a424288e3b07da18","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/eec1995cebd24287a424288e3b07da18","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematologica, Vol 110, Iss s1 (2025)","raw_type":"article"},"volume":null,"type":"article","indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/eec1995cebd24287a424288e3b07da18","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"G. Fornari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Fornari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"D. Cilloni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Cilloni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A. Ferrero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Ferrero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"G. Valabrega","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Valabrega","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.52694002,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/romiplostim","display_name":"romiplostim","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chemotherapy-induced-thrombocytopenia","display_name":"chemotherapy-induced thrombocytopenia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/thrombopoietin-receptor-agonists","display_name":"thrombopoietin receptor agonists","score":0.9369999766349792},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9020000100135803},{"id":"https://openalex.org/keywords/platelet-recovery","display_name":"platelet recovery","score":0.8019999861717224},{"id":"https://openalex.org/keywords/chemotherapy-dose-intensity","display_name":"chemotherapy dose intensity","score":0.6430000066757202},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.8360000252723694},{"id":"https://openalex.org/keywords/bone-marrow-involvement","display_name":"bone marrow involvement","score":0.8709999918937683},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C2776915898","wikidata":"https://www.wikidata.org/wiki/Q1235195","display_name":"Romiplostim","level":5,"score":0.9603000283241272},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8614000082015991},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6162999868392944},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6017000079154968},{"id":"https://openalex.org/C2778713057","wikidata":"https://www.wikidata.org/wiki/Q18029261","display_name":"Thrombopoietin receptor","level":5,"score":0.5623999834060669},{"id":"https://openalex.org/C2777863708","wikidata":"https://www.wikidata.org/wiki/Q424519","display_name":"Thrombopoietin","level":4,"score":0.4790000021457672},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4691999852657318},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46239998936653137},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.447299987077713},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.42100000381469727},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3959999978542328},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3873000144958496},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.37860000133514404},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3637999892234802},{"id":"https://openalex.org/C2776689292","wikidata":"https://www.wikidata.org/wiki/Q23925170","display_name":"Platelet transfusion","level":3,"score":0.3418999910354614},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3312000036239624},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.31049999594688416},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.3095000088214874},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.30730000138282776},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.2946999967098236},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.28439998626708984},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.26750001311302185},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.2662999927997589},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.2653999924659729},{"id":"https://openalex.org/C2780588981","wikidata":"https://www.wikidata.org/wiki/Q411588","display_name":"Eltrombopag","level":4,"score":0.257999986410141}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:eec1995cebd24287a424288e3b07da18","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/eec1995cebd24287a424288e3b07da18","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematologica, Vol 110, Iss s1 (2025)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:eec1995cebd24287a424288e3b07da18","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/eec1995cebd24287a424288e3b07da18","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematologica, Vol 110, Iss s1 (2025)","raw_type":"article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8448590636253357}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Chemotherapy-induced":[0],"thrombocytopenia":[1,145],"(CIT)":[2],"is":[3],"a":[4,42,50],"common":[5],"hematologic":[6],"complication":[7],"of":[8,21,96,154,189],"cancer":[9,76],"treatment,":[10],"characterized":[11],"by":[12],"decreased":[13],"platelet":[14,89,126,178],"counts":[15],"due":[16],"to":[17,121,173],"the":[18,64,100,113,152,184],"cytotoxic":[19],"effects":[20],"chemotherapy":[22,38,97,130],"on":[23,105,170],"megakaryocytes.":[24],"This":[25,57],"condition":[26],"poses":[27],"significant":[28],"clinical":[29],"challenges,":[30],"including":[31],"bleeding":[32],"risks,":[33],"treatment":[34,92,110,175],"delays,":[35,93],"and":[36,66,81,94,109,143,158,182,187],"compromised":[37],"dose":[39],"intensity.":[40],"Romiplostim,":[41],"thrombopoietin":[43],"receptor":[44],"agonist":[45],"(TPO-RA),":[46],"has":[47],"emerged":[48],"as":[49],"promising":[51],"therapeutic":[52],"option":[53],"for":[54,115,180],"CIT":[55,73,106,163],"management.":[56],"paper":[58,101],"presents":[59,146],"three":[60],"case":[61],"reports":[62],"highlighting":[63],"efficacy":[65,188],"challenges":[67],"associated":[68],"with":[69,139],"romiplostim":[70,160],"in":[71,74,124,137],"treating":[72],"breast":[75],"patients":[77,138],"undergoing":[78],"chemotherapy.":[79],"Weekly":[80],"biweekly":[82],"administration":[83],"protocols":[84],"were":[85],"evaluated,":[86],"demonstrating":[87],"successful":[88],"recovery,":[90],"reduced":[91],"maintenance":[95],"regimens.":[98],"Additionally,":[99],"reviews":[102],"current":[103],"literature":[104],"epidemiology,":[107],"pathophysiology,":[108],"strategies,":[111],"emphasizing":[112],"need":[114],"individualized":[116],"approaches.":[117],"Romiplostim":[118],"was":[119],"shown":[120],"be":[122],"effective":[123],"increasing":[125],"counts,":[127],"enabling":[128],"continued":[129],"while":[131],"maintaining":[132],"safety.":[133],"However,":[134],"its":[135],"use":[136],"bone":[140],"marrow":[141],"infiltration":[142],"relapsed":[144],"nuanced":[147],"challenges.":[148],"These":[149],"findings":[150],"underscore":[151],"importance":[153],"optimizing":[155],"dosing":[156],"schedules":[157],"integrating":[159],"into":[161],"personalized":[162],"management":[164],"strategies.":[165],"Future":[166],"research":[167],"should":[168],"focus":[169],"controlled":[171],"trials":[172],"refine":[174],"protocols,":[176],"lower":[177],"thresholds":[179],"chemotherapy,":[181],"explore":[183],"long-term":[185],"safety":[186],"TPO-RA-based":[190],"therapies.":[191]},"counts_by_year":[],"updated_date":"2026-05-06T06:10:43.113611","created_date":"2025-10-22T00:00:00"}